US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

ホーム
投資
株式
ドイツ
TG
SLM Corp (SM1) 銘柄情報

SLM Corp (SM1)

22.40

0.00

( 0.00% )

更新日時： 20:47:50

SLM Corp (SM1) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

22.40

( - )

買値

22.20

売値

22.60

出来高

0.00

0.00 日の範囲 0.00

15.90 52 週間の範囲 28.80

時価総額

前日終値

22.40

始値

-

時刻

最終取引時間

-

財務取引量

-

VWAP

-

平均取引量 (3 か月)

2,985,402 €

発行済株式数

188,592,995

配当利回り

0.52 (2.18%)

PER

7.23

1 株当たり利益 (EPS)

3.55

歳入

1.67B

純利益

748.26M

SLM Corporation, through its subsidiaries, originates and services private education loans to students and their families to finance the cost of their education in the United States. It provides retail deposit accounts, including high-yield savings accounts, money market accounts, and certificates o... SLM Corporation, through its subsidiaries, originates and services private education loans to students and their families to finance the cost of their education in the United States. It provides retail deposit accounts, including high-yield savings accounts, money market accounts, and certificates of deposit; and interest-bearing omnibus accounts. The company was formerly known as New BLC Corporation and changed its name to SLM Corporation in December 2013. SLM Corporation was founded in 1972 and is headquartered in Newark, Delaware. 詳細を表示

セクター

Finance

業界

Credit Finance

ウェブサイト

www.salliemae.com

本社

Newark, United States

設立

1972

SLM Corp is listed in the Finance sector of the Tradegate (DE) with ticker SM1. The last closing price for SLM was 22.40 €. Over the last year, SLM shares have traded in a share price range of 15.90 € to 28.80 €.

SLM currently has 188,592,995 shares in issue. The market capitalisation of SLM is 4.22 € billion. SLM has a price to earnings ratio (PE ratio) of 7.23.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.4	-1.75438596491	22.8	22.8	22.8	250	22.8	DE
4	2.8	14.2857142857	19.6	22.8	18.8	1431	20.26924749	DE
12	4.3	23.7569060773	18.1	22.8	18.1	733	20.10383561	DE
26	-1.2	-5.08474576271	23.6	24.6	15.9	437	19.48299053	DE
52	-6.4	-22.2222222222	28.8	28.8	15.9	295	21.09063689	DE
156	8.8	64.7058823529	13.6	30.8	12.3	436	21.09355366	DE
260	8.8	64.7058823529	13.6	30.8	12.3	436	21.09355366	DE

SM1 - Frequently Asked Questions (FAQ)

What is the current SLM Corp share price?

The current share price of SLM Corp is 22.40 €

How many SLM Corp shares are in issue?

SLM Corp has 188,592,995 shares in issue

What is the market cap of SLM Corp?

The market capitalisation of SLM Corp is EUR 4.22B

What is the 1 year trading range for SLM Corp share price?

SLM Corp has traded in the range of 15.90 € to 28.80 € during the past year

What is the PE ratio of SLM Corp?

The price to earnings ratio of SLM Corp is 7.23

What is the cash to sales ratio of SLM Corp?

The cash to sales ratio of SLM Corp is 2.91

What is the registered address of SLM Corp?

The registered address for SLM Corp is 300 Continental Drive, Newark, Delaware, 19713

What is the SLM Corp website address?

The website address for SLM Corp is www.salliemae.com

Which industry sector does SLM Corp operate in?

SLM Corp operates in the Credit Finance sector

j e d

This is the biggest thing since the Advent acquisition, if not bigger.

JAB65

Never thought about that. That would certainly save them a few hundred million. Is there enough capacity, compression or whatever the criteria is to piggyback on Williams? Would they prefer to have their own control with a new station?

fredscott36

fredscott36 3分前

..dude......will get 'em both, and the G-wagon is ordered, and the 4-runner......not firm on the wrangler, but definitely a wrangler............gotta fill up the garages with a new fleet.........boys toys................($40mios in the tip jar??)...............

.....the POS.....???.

US Market News

US Market News 4分前

Robert Half receives three Canadian HR Reporter Readers' Choice Awards 2026, for 11th consecutive yearJuly 3, 2026 12:38 PM
PR Newswire (Canada) class="legendSpanClass"TORONTO, class="legendSpanClass"July 3, 2026 /CNW/ - Global talent so

KeepItRealistic

KeepItRealistic 5分前

$OSRH to new long investors buy 10k shares and HOLD and while turning your 10k shares to 60k shares 👇

• Details: One non-transferable CVR per share held as of the record date (targeted for July 31, 2026). Subject to legal counsel approval.

• Tiered Rewards: T

williamssc

williamssc 7分前

Slide16 “Overall Conclusions: The survival benefit associated with DCVax-L treatment reflects a true treatment affect and was underestimated in the original analysis”

https://nwbio.com/wp-content/uploads/NWBT-BNOS-slides-7-3-26MB-LP-final.pdf

NASDAQ2020

NASDAQ2020 9分前

i will wait for Monday to grab some more ??

GoodGuyBill

GoodGuyBill 9分前

Brazen22, you’re trying to reduce three years of regulatory progress to one sentence: “You don’t have an approved MAA.”

Of course we don’t — yet. Approval is the destination. We have a validated MAA. What matters is whether NWBO has completed the steps that regulators require before a

NASDAQ2020

NASDAQ2020 9分前

THATS WHEN i ACCUMULATE. At The hammerbottom.

nowwhat2

nowwhat2 9分前

Nonbelievers . . . . . C L E A R The R U N W A Y
$3.50 CDN is pretty strong support.

https://investorshub.advfn.com/uimage/uploads/2026/7/3/vwgethg_july_3_2y_plunge_sell.jpg

rizona

rizona 11分前

Slides! JAMA study UNDERESTIMATED survival benefit

https://nwbio.com/wp-content/uploads/NWBT-BNOS-slides-7-3-26MB-LP-final.pdf

rosemountbomber

rosemountbomber 12分前

I agree with your thinking and also what needs to be considered is after decimating the board, just a desire to be acquired doesn’t automatically make that happen. Some other party has to be interested in acquiring Amarin. What happens then if no one steps up?

chereb19

chereb19 13分前

This is another post built on false equivalence. Sharing Y-90 doesn't make two products the same any more than sharing aspirin makes every painkiller identical.

You keep calling them competitors while ignoring they're fundamentally different technologies. One is a hydrogel platform, t

NASDAQ2020

NASDAQ2020 14分前

Im glad I held my shares past $0.15

Idunno

Idunno 14分前

And don’t forget your buddy, AF. … .. .

Doc logic

Doc logic 14分前

HappyLibrarian,

You are mistakenly overstating my claim which is a common problem so no harm no foul. Manufacturing transition preparedness is what I am suggesting must be in place. Artisan will be utilized to start as NWBO has consistently stated and the MIA is based on that model.

rcaselli

rcaselli 15分前

Just knowing JCTB1 is here is good enuf for me, okay.
See ya all topside….
$LBRG

Idunno

Idunno 15分前

Have at it Brazen! ;) … .. . :)

CatfishHunter

CatfishHunter 17分前

Every biotech founder believes their design choice was the right one — that’s true of BetaGlue’s surgeon-founder and it was true of Fisher/Korenko too. Design rationale explains intent, not outcome. The question that matters is what the trial data shows for each product, not why either team picked t

asp42001

asp42001 17分前

Digital USIO & AI Payment Potential:

(USIO In-Part):

"Embedded payments are the hidden engine under the hood of the apps and platforms we use every day. When you buy a ticket through a sports app or pay for a round of golf lessons online, embedded payments are doing the

BigBadWolf

BigBadWolf 18分前

$Ownership😘 of @ this point w/ irrefutable DD
🤔https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177573771&txt2find=reactor

mgland

mgland 19分前

https://x.com/thommic/status/2072760144774005081

GTF

Just so you know the clock on the 12 month restricted period for SNTX divvy shares began on June 17th, 2026. It doesn't matter that the deliverance of shares to the gtvh shareholders is taking some time. The clock begins when SNTX creates and issues the shares...meaning the day OTCmarkets shows the

manibiotech

manibiotech 21分前

I like this line in couple of PSM analysis slides:

“ Conclusion: Based on these more precisely matched comparisons,
the survival benefit with DCVax-L was likely underestimated
in the original analysis”

Very encouraging . Now let’s see when MHRA does its jo

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。